ResearcherNingbo UniversityActive in the last 2 years

Xiaolan He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-1548-1993; OpenAlex author ID A5101565764. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 2 papers

Papers 2

A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarci… Co-author DOI 10.1016/j.heliyon.2023.e23659 ↗
[Construction and Evaluation of a Prognostic Risk Prediction Model of Pancreatic Ductal Adenocarcinoma Based on Immune-Related Genes]. Last author DOI 10.3881/j.issn.1000-503x.15736 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu Zhang · 1 shared paper, 2024 · strength 0.31
- Paper [Construction and Evaluation of a Prognostic Risk Prediction Model of Pancreatic Ductal Adenocarcinoma Based on Immune-… DOI 10.3881/j.issn.1000-503x.15736 ↗
Ying Han · 1 shared paper, 2024 · strength 0.24
- Paper A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and thera… DOI 10.1016/j.heliyon.2023.e23659 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.